Point-of-Care Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

Point-of-Care Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

  • June 2020 •
  • 115 pages •
  • Report ID: 5917316 •
  • Format: PDF
The global point-of-care diagnostics market grew at a CAGR of 9.5% during 2014-2019. Point-of-care (PoC) diagnostics refer to the medical testing conducted to enable rapid analysis and obtain immediate results. PoC testing involves various portable instruments for glucose monitoring and infectious disease, cardiometabolic and urinalysis testing, among others. It aids in the early detection of critical illnesses, thus providing an enhanced patient-centric approach of healthcare. This kind of medical testing is widely utilized for supplying diagnostic facilities to remote locations where it is difficult to set up clinical laboratories. Owing to this, PoC testing essentials are integrated with medical vehicles, including helicopters, air ambulances, airplanes and spacecraft.

The growing prevalence of chronic diseases, which lead to increased morbidity and mortality rates, is one of the key factors driving the growth of the market. Furthermore, the increasing geriatric population across the globe, which is more prone to chronic illnesses, is also providing a thrust to the market. Moreover, infectious diseases such as Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), dengue fever, malaria and influenza require timely diagnosis and rapid screening, which is usually done through PoC diagnostic devices. Additionally, owing to the development of miniaturized devices and the integration with wireless technology, healthcare professionals can maintain electronic medical records (EMR) and provide more personalized intervention to individual patients. These records enable the direct transmission of test results from PoC devices to a specialist in the lab, thus minimizing the chances of discrepancies in the obtained test results. Moreover, the advent of home-testing cancer kits, which can actively monitor and analyze tumor cells, is further acting as a growth-inducing factor. Other factors, including enhanced research and development (R&D) to develop molecular diagnostic devices and the rising awareness for early detection of diseases, are projected to drive the market growth. Looking forward, the analyst expects the market to continue its strong growth during the next five years.

Breakup by Product Type:
Blood-Glucose Monitoring Kit
Cardio-Metabolic Monitoring Kit
Pregnancy and Fertility Testing Kit
Infectious Disease Testing Kit
Cholesterol Test Strip
Hematology Testing Kit
Others

Breakup by Platform:
Lateral Flow Assays
Dipsticks
Microfluidics
Molecular Diagnostics
Immunoassays

Breakup by Prescription Mode:
Prescription-Based Testing
OTC Testing

Breakup by End-User:
Professional Diagnostic Centers
Home Care
Research Laboratories
Others

Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Beckman Coulter, Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Instrumentation Laboratory, Johnson & Johnson, Nova Biomedical Corporation, Pts Diagnostics, Qiagen, Siemens, Trinity Biotech, etc.

Key Questions Answered in This Report:
How has the global point-of-care diagnostics market performed so far and how will it perform in the coming years?
What are the key regional markets?
What is the breakup of the market based on the product type?
What is the breakup of the market based on the platform?
What is the breakup of the market based on the prescription mode?
What is the breakup of the market based on the end-user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global point-of-care diagnostics market and who are the key players?
What is the degree of competition in the industry?